Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,335 public trials 329 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Active, Not Recruiting

Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer

NCT02417662

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UCLH London, England, United Kingdom
  • Belfast City Hospital Belfast, United Kingdom
  • Queen Elizabeth Hospital Birmingham, United Kingdom
  • Bristol Royal Infirmary Bristol, United Kingdom
View all 19 locations
View Trial Details
Active, Not Recruiting

New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy

NCT04564157

Conditions
Adjuvant Chemotherapy, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Hospital General Universitario de Alicante Alicante, Spain
  • ICO Badalona, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Universitari Quiron Dexeus Barcelona, Spain
  • Hospital Universitari Vall d' Hebron Barcelona, Spain
View all 30 locations
View Trial Details
Active, Not Recruiting

TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)

NCT01888601

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The Princess Alexandra Hospital NHS Trust Harlow, Essex, United Kingdom
  • University Hospital Southampton NHS Foundation Trust Southampton, Hampshire, United Kingdom
  • University College London Hospitals NHS Foundation Trust London, Select Region, United Kingdom
  • Ashford and St Peter's Hospitals NHS Foundation Trust Chertsey, Surrey, United Kingdom
View all 18 locations
View Trial Details
Active, Not Recruiting

Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E Mutated Chinese Patients With Metastatic Non-Small Cell Lung Cancer

NCT05195632

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Beijing Chest Hospital, Capital Medical University Beijing, China
  • Peking University First Hospital Beijing, China
  • The First Hospital of Jilin University Changchun, China
View all 34 locations
View Trial Details
Active, Not Recruiting

Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]

NCT02486718

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • California Cancer Associates for Research & Excellence, Inc. Encinitas, California, United States
  • Compassionate Cancer Care Medical Group, Inc Fountain Valley, California, United States
  • University of California Los Angeles Los Angeles, California, United States
View all 154 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

NCT04913285

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +25 more
Locations
  • The Angeles Clinic Los Angeles, California, United States
  • UCLA Los Angeles, California, United States
  • University of California San Diego, Moores Cancer Center San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
View all 50 locations
View Trial Details
Active, Not Recruiting

Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008)

NCT06049212

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • Aichi Cancer Center ( Site 0006) Nagoya, Aichi-ken, Japan
  • National Cancer Center Hospital East ( Site 0002) Kashiwa, Chiba, Japan
  • National Hospital Organization Shikoku Cancer Center ( Site 0008) Matsuyama, Ehime, Japan
  • Kanagawa Cancer Center ( Site 0004) Yokohama, Kanagawa, Japan
View Trial Details

Related conditions